Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.83%
After-hours: Aug 15, 2025, 07:35 PM EDT

Voyager Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-65M 132.33M -46.41M -71.2M
Depreciation & Amortization
4.73M 4.44M 6.19M 5.17M
Stock-Based Compensation
14.79M 11.15M 9.34M 11.32M
Other Working Capital
-48.84M 17.64M 18M -1.72M
Other Non-Cash Items
-4.68M -3.45M -2.11M -2.46M
Deferred Income Tax
n/a n/a n/a 349K
Change in Working Capital
34.86M -66.56M 20.47M 3.29M
Operating Cash Flow
-15.31M 77.92M -12.51M -53.52M
Capital Expenditures
-3.52M -3.26M -2.49M -1.61M
Cash Acquisitions
n/a 138.39M 4.85M -2.46M
Purchase of Investments
-465.69M -223.97M -54.85M -15.12M
Sales Maturities Of Investments
374.35M 85.58M 50M 82.63M
Other Investing Acitivies
n/a -138.39M -4.85M 2.46M
Investing Cash Flow
-94.86M -141.64M -7.34M 65.91M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a 481K 584K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.24M 2.52M 1.11M 612K
Financial Cash Flow
114.02M 33.65M 1.11M 612K
Net Cash Flow
3.85M -30.08M -18.74M 12.99M
Free Cash Flow
-18.83M 74.66M -15M -55.13M